Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Fujitani

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
Biochemical and Biophysical Research Communications|October 10, 2013
Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db miceKeita Ishibashi, Akemi Hara, Yoshio Fujitani, et al.
Endocrine Journal|March 8, 2019
Development of monoclonal mouse antibodies that specifically recognize pancreatic polypeptideAkemi Hara, Yuko Nakagawa, Keiko Nakao, et al.
Diabetes Research and Clinical Practice|October 7, 2016
Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP)Yoshio Fujitani, Shimpei Fujimoto, Kiyohito Takahashi, et al.
The Journal of Biological Chemistry|February 5, 2002
Protein kinase C-dependent, CCAAT/enhancer-binding protein beta-mediated expression of insulin-like growth factor I geneYutaka Umayahara, Yoshitaka Kajimoto, Yoshio Fujitani, et al.
Biochemical and Biophysical Research Communications|August 7, 2007
Establishment of a non-invasive mouse reporter model for monitoring in vivo pdx-1 promoter activityToshihiko Shiraiwa, Hideaki Kaneto, Takeshi Miyatsuka, et al.
Endocrinology|January 23, 2013
Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient miceNasib Ervinna, Tomoya Mita, Eisuke Yasunari, et al.
International Journal of Endocrinology|July 24, 2014
Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patientsToyoyoshi Uchida, Takatoshi Kasai, Atsutoshi Takagi, et al.
The Journal of International Medical Research|December 10, 2015
Effect of treatment guidance using a retrospective continuous glucose monitoring system on glycaemic control in outpatients with type 2 diabetes mellitus: A randomized controlled trialJunko Sato, Akio Kanazawa, Fuki Ikeda, et al.
Endocrine Journal|June 2, 2010
Superior thyroid artery mean peak systolic velocity for the diagnosis of thyrotoxicosis in Japanese patientsToyoyoshi Uchida, Kageumi Takeno, Masahiro Goto, et al.
BMC Endocrine Disorders|June 19, 2015
Poor sleep quality is associated with increased arterial stiffness in Japanese patients with type 2 diabetes mellitusYusuke Osonoi, Tomoya Mita, Takeshi Osonoi, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Biochemical and Biophysical Research Communications|October 10, 2013
Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db miceKeita Ishibashi, Akemi Hara, Yoshio Fujitani, et al.
Endocrine Journal|March 8, 2019
Development of monoclonal mouse antibodies that specifically recognize pancreatic polypeptideAkemi Hara, Yuko Nakagawa, Keiko Nakao, et al.
Diabetes Research and Clinical Practice|October 7, 2016
Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP)Yoshio Fujitani, Shimpei Fujimoto, Kiyohito Takahashi, et al.
The Journal of Biological Chemistry|February 5, 2002
Protein kinase C-dependent, CCAAT/enhancer-binding protein beta-mediated expression of insulin-like growth factor I geneYutaka Umayahara, Yoshitaka Kajimoto, Yoshio Fujitani, et al.
Biochemical and Biophysical Research Communications|August 7, 2007
Establishment of a non-invasive mouse reporter model for monitoring in vivo pdx-1 promoter activityToshihiko Shiraiwa, Hideaki Kaneto, Takeshi Miyatsuka, et al.
Endocrinology|January 23, 2013
Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient miceNasib Ervinna, Tomoya Mita, Eisuke Yasunari, et al.
International Journal of Endocrinology|July 24, 2014
Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patientsToyoyoshi Uchida, Takatoshi Kasai, Atsutoshi Takagi, et al.
The Journal of International Medical Research|December 10, 2015
Effect of treatment guidance using a retrospective continuous glucose monitoring system on glycaemic control in outpatients with type 2 diabetes mellitus: A randomized controlled trialJunko Sato, Akio Kanazawa, Fuki Ikeda, et al.
Endocrine Journal|June 2, 2010
Superior thyroid artery mean peak systolic velocity for the diagnosis of thyrotoxicosis in Japanese patientsToyoyoshi Uchida, Kageumi Takeno, Masahiro Goto, et al.
BMC Endocrine Disorders|June 19, 2015
Poor sleep quality is associated with increased arterial stiffness in Japanese patients with type 2 diabetes mellitusYusuke Osonoi, Tomoya Mita, Takeshi Osonoi, et al.
Pageof 14